Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
01/21/2009 | EP2017335A1 Mutated Abl kinase domains |
01/21/2009 | EP2017332A1 Microorganism capable of producing l-amino acid, and process for production of l-amino acid |
01/21/2009 | EP2017287A2 Method of producing hydroxyalkyl starch derivatives |
01/21/2009 | EP2017286A2 Transporter genes |
01/21/2009 | EP2017284A1 New polypeptides inducing apoptosis and uses thereof |
01/21/2009 | EP2017262A1 Process for production of carotenoid |
01/21/2009 | EP2016953A2 Vascular endothelial cell growth factor antagonists and uses thereof |
01/21/2009 | EP2016951A1 Polypeptides homologous to VEGF and BMP1 |
01/21/2009 | EP2016821A1 New hybrid system for Brassica napus |
01/21/2009 | EP2016183A1 Process for chromosomal engineering using a novel dna repair system |
01/21/2009 | EP2016182A1 Mutant hsv, materials and methods for generation of mutant hsv |
01/21/2009 | EP2016181A2 Methods and compositions for obtaining marker-free transgenic plants |
01/21/2009 | EP2016180A2 Plant artificial chromosome platforms via telomere truncation |
01/21/2009 | EP2016179A2 Transgenic plants exhibiting increased tolerance to stress and methods of generating same |
01/21/2009 | EP2016178A2 Microbial intestinal delivery of obesity related peptides |
01/21/2009 | EP2016177A2 Compositions and their uses directed to hepcidin |
01/21/2009 | EP2016176A1 Plasmid curing |
01/21/2009 | EP2016089A1 Gene defects and mutant alk kinase in human solid tumors |
01/21/2009 | EP2015774A1 Influenza virus vaccine |
01/21/2009 | EP2015760A1 Use of cells containing a specific dna molecule as cytopathic agents to inhibit the proliferation of cells |
01/21/2009 | EP2015758A2 Compounds and methods for modulating expression apob |
01/21/2009 | EP1945761A4 Arachnocampa luciferases |
01/21/2009 | EP1934606A4 Optimized trpm8 nucleic acid sequences and their use in cell based assays and test kits to identify trpm8 modulators |
01/21/2009 | EP1929011A4 Nucleic acid extraction method |
01/21/2009 | EP1909559A4 Management of plant pathogens |
01/21/2009 | EP1907844A4 Method of manufacturing probe-immobilized carrier |
01/21/2009 | EP1879444A4 Methods of producing and growing plants having improved phosphorus utilization |
01/21/2009 | EP1851239B1 Replication-deficient rna viruses as vaccines |
01/21/2009 | EP1774041A4 Compositions and methods for preparation of nucleic acids from microbial samples |
01/21/2009 | EP1718753A4 Methods for making and using molecular switches involving circular permutation |
01/21/2009 | EP1585770B1 Recognition molecules for the treatment and detection of tumours |
01/21/2009 | EP1567175B1 Sterile immunogenic non-tumorigenic tumor cell compositions and methods |
01/21/2009 | EP1495330B1 Method of identifying transmembrane protein-interacting compounds |
01/21/2009 | EP1490691B1 Luminescent, spheroid, non-autofluorescent silica gel particles having variable emission intensities and frequencies |
01/21/2009 | EP1483375B1 A method for producing recombinant adenovirus viruses using site-specific recombination |
01/21/2009 | EP1432443B1 Angiotensin peptide-carrier conjugates and uses thereof |
01/21/2009 | EP1399563B1 Moraxella (branhamella) catarrhalis antigens |
01/21/2009 | EP1373480B1 Uncoupled productive and catabolic host cell pathways |
01/21/2009 | EP1353691B1 Molecular antigen array presenting amyloid beta |
01/21/2009 | EP1335973B1 human adenylate cyclase |
01/21/2009 | EP1328810B1 Three dimensional format biochip |
01/21/2009 | EP1307588B1 Method for diagnosing or determining a risk for psychosis comprising determining an heterozygous mutation of methylenetetrahydrofolate reductase (MTHFR) |
01/21/2009 | EP1301627B1 Improved detection signal and capture in dipstick assays |
01/21/2009 | EP1294906B1 Whole-body optical imaging of gene expression and uses thereof |
01/21/2009 | EP1261701B1 FULL-LENGTH INFECTIOUS cDNA CLONES OF TICK BORNE FLAVIVIRUS |
01/21/2009 | EP1234880B1 Novel protein tab2 |
01/21/2009 | EP1177281B1 Isolation of nucleic acid |
01/21/2009 | EP1129209B1 Polymer grafting by polysaccharide synthases |
01/21/2009 | EP1105495B2 Method for producing yeast expressed hpv types 6 and 16 capsid proteins |
01/21/2009 | EP1032654B1 Thermostable glucoamylase |
01/21/2009 | EP1019438B1 Apoptosis-related compounds and their use |
01/21/2009 | EP1003890B1 Plant fatty acid synthases and use in improved methods for production of medium-chain fatty acids |
01/21/2009 | EP0993468B1 Compositions and methods for activating genes of interest |
01/21/2009 | EP0985731B1 Mutated alpha-amylases |
01/21/2009 | EP0975760B1 Motilin homologs |
01/21/2009 | EP0917578B1 Novel strains of escherichia coli, methods of preparing the same and use thereof in fermentation processes for l-threonine production |
01/21/2009 | EP0904276B1 A plant nuclear scaffold attachment region which increases gene expression |
01/21/2009 | EP0826057B1 Bioconversion of a fermentable carbon source to 1,3-propanediol by a single microorganism |
01/21/2009 | CN101351564A Detection of nucleic acids by target-specific hybrid capture method |
01/21/2009 | CN101351557A Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with RNA virus or DNA virus spike protein |
01/21/2009 | CN101351556A Plants having improved growth characteristics and a method for making the same |
01/21/2009 | CN101351555A A new selection system for wheat |
01/21/2009 | CN101351554A Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
01/21/2009 | CN101351553A A method for in vitro molecular evolution of protein function |
01/21/2009 | CN101351552A Paired end sequencing |
01/21/2009 | CN101351551A Novel protein and DNA encoding the protein |
01/21/2009 | CN101351550A Chimaeric fusion protein with superior chaperone and folding activities |
01/21/2009 | CN101351548A Novel polypeptide having esterase activity and recombinant esterase and use thereof |
01/21/2009 | CN101351545A Materials and methods for treating chronic fibrotic disease |
01/21/2009 | CN101351478A Uses of anti-CD40 antibodies |
01/21/2009 | CN101351477A Anti-CD19 antibodies with reduced immunogenicity |
01/21/2009 | CN101351475A Interleukin-12p40 variants with improved stability |
01/21/2009 | CN101351229A Therapeutic method for blood coagulation disorder |
01/21/2009 | CN101351228A Immune stimulation speciality of compound containing modified immune irritation dinucleotide base on oligonucleotide |
01/21/2009 | CN101351224A Hypoallergenic variants of the major allergen from Betula verrucosa pollen |
01/21/2009 | CN101351213A Systemic treatment of metastatic and/or systemically-disseminated cancers using GM-CSF-expressing poxviruses |
01/21/2009 | CN101348837A Probe, primer and reagent kit for realtime fluorescent quantitative RT-PCR detection of classical swine fever virus |
01/21/2009 | CN101348833A ITS sequence of Tremella aurantiablba Bandoni and Stereum hirsutum and method for identifying golden fungus using the same |
01/21/2009 | CN101348832A Clone and use of molecular marker related to pig growth and meat quality traits |
01/21/2009 | CN101348830A Hybrid Chinese tuliptree rapid molecular detection specific primer and use method thereof |
01/21/2009 | CN101348823A Use of reporter plasmid for biological detection of radioactive ray dose |
01/21/2009 | CN101348822A Reporter plasmid for biological detection of radioactive ray dose and construction method thereof |
01/21/2009 | CN101348801A Method for preparing animal cellular membrane and cellular organ membrane protein |
01/21/2009 | CN101348800A Method for efficiently obtaining animal membrane protein by means of togavirus budding characteristic |
01/21/2009 | CN101348799A Construction method and pharmaceutical use of microRNA adenovirus expression plasmid for severe hepatitis related gene hfg12, hFas and hTNFR1 |
01/21/2009 | CN101348798A Construction of recombinant adenovirus vector expressing bFGF protein and use of recombinant adenovirus vector for in vivo ear transfection |
01/21/2009 | CN101348797A Chaetomium cupreum chitinase gene, encoding amino acid sequence thereof and primer for cloning |
01/21/2009 | CN101348796A Chaetomium cupreum chitinase gene codon preference mutant gene, preparation thereof and used primer |
01/21/2009 | CN101348795A Encoding gene of glucose oxidase, preparation and use thereof |
01/21/2009 | CN101348794A Encoding gene of high activity glucose oxidase, preparation and use thereof |
01/21/2009 | CN101348793A Insecticidal proteins from bacillus thuringiensis |
01/21/2009 | CN101348792A Plant-optimized polynucleotides encoding approximately 15 kDa and approximately 45 kda pesticidal proteins |
01/21/2009 | CN101348791A Populus euphratica Oliv hydrotropic gene PeXET and promoter thereof |
01/21/2009 | CN101348790A Method for enhancing plant adverse resistance ability by means of rice transcription factor OsbZIP23 |
01/21/2009 | CN101348789A Production of human mutant proteins in human cells by homologous recombination |
01/21/2009 | CN101348788A Cell proliferation related gene CNKSR3, screening method and use thereof |
01/21/2009 | CN101348787A Preparation and use of giant panda Ascaris schroederi antigen |
01/21/2009 | CN101348786A Human ª-globin gene and recombinant adeno related viral vector thereof |
01/21/2009 | CN101348785A Regulation of viral gene expression |
01/21/2009 | CN101348784A Method for extracting nucleic acid from edible fat |